A UK study released Tuesday reports that coffee consumption results in lower rates of chronic liver disease. Coffee drinkers report lower and less serious rates of chronic liver disease (CLD), a new UK-based Biobank study found. The study was published on Tuesday in BMC, a collection of peer-reviewed medicine, science and technology journals. Among lower and middle-income countries, CLD is causing increased morbidity and mortality rates, the study found. The study included data on 494,585 coffee consumers aged 40-69 along with hospital, death, and cancer rates. The participants were mostly from urban areas and were examined across the Biobank hospital network.